NO973612L - Nytt farmasöytisk preparat - Google Patents

Nytt farmasöytisk preparat

Info

Publication number
NO973612L
NO973612L NO973612A NO973612A NO973612L NO 973612 L NO973612 L NO 973612L NO 973612 A NO973612 A NO 973612A NO 973612 A NO973612 A NO 973612A NO 973612 L NO973612 L NO 973612L
Authority
NO
Norway
Prior art keywords
pharmaceutical preparation
new pharmaceutical
new
preparation
pharmaceutical
Prior art date
Application number
NO973612A
Other languages
English (en)
Other versions
NO314220B1 (no
NO973612D0 (no
Inventor
Johan Georg Harmenberg
Ann Harriet Marg Kristofferson
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of NO973612D0 publication Critical patent/NO973612D0/no
Publication of NO973612L publication Critical patent/NO973612L/no
Publication of NO314220B1 publication Critical patent/NO314220B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
NO19973612A 1995-02-06 1997-08-05 Farmasöytisk preparat for dermal eller mukosal administrasjon, og anvendelse derav NO314220B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9500114 1995-02-06
PCT/SE1996/000124 WO1996024355A1 (en) 1995-02-06 1996-02-02 Novel pharmaceutical combination

Publications (3)

Publication Number Publication Date
NO973612D0 NO973612D0 (no) 1997-08-05
NO973612L true NO973612L (no) 1997-09-26
NO314220B1 NO314220B1 (no) 2003-02-17

Family

ID=20396821

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19973612A NO314220B1 (no) 1995-02-06 1997-08-05 Farmasöytisk preparat for dermal eller mukosal administrasjon, og anvendelse derav

Country Status (30)

Country Link
US (2) USRE39264E1 (no)
EP (2) EP0809498B1 (no)
JP (2) JP4260220B2 (no)
KR (1) KR100431042B1 (no)
CN (1) CN1131034C (no)
AR (1) AR002030A1 (no)
AT (2) ATE421358T1 (no)
AU (1) AU716809B2 (no)
CA (1) CA2211389C (no)
DE (3) DE69637828D1 (no)
DK (1) DK0809498T3 (no)
DZ (1) DZ1966A1 (no)
ES (1) ES2214528T3 (no)
FI (1) FI119415B (no)
FR (1) FR10C0038I2 (no)
HK (1) HK1004368A1 (no)
HR (1) HRP960034B1 (no)
IL (1) IL116913A0 (no)
MA (1) MA23800A1 (no)
MY (1) MY119365A (no)
NO (1) NO314220B1 (no)
NZ (1) NZ301407A (no)
PT (1) PT809498E (no)
SA (1) SA96160590B1 (no)
SI (1) SI0809498T1 (no)
TN (1) TNSN96024A1 (no)
TW (1) TW438585B (no)
WO (1) WO1996024355A1 (no)
YU (1) YU49477B (no)
ZA (1) ZA96527B (no)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9601544D0 (en) 1996-01-26 1996-03-27 Smithkline Beecham Plc Pharmaceuticals
IT1287114B1 (it) * 1996-10-31 1998-08-04 Recordati Chem Pharm Composizioni farmaceutiche antierpetiche per applicatori topici, contenenti aciclovir
SE9803929D0 (sv) * 1998-11-18 1998-11-18 Medivir Ab Antiviral formulation
US7223387B2 (en) 1998-11-18 2007-05-29 Medivir Ab Antiviral formulations comprising propylene glycol and an isopropyl alkanoic acid ester
US7767216B2 (en) * 1999-04-28 2010-08-03 The Regents Of The University Of Michigan Antimicrobial compositions and methods of use
US7655252B2 (en) 1999-04-28 2010-02-02 The Regents Of The University Of Michigan Antimicrobial nanoemulsion compositions and methods
FR2837102B1 (fr) * 2002-03-18 2004-10-08 Palbian Snc Composition a l'etat de gel aqueux, procede de fabrication et utilisation pour la fabrication d'un medicament, notamment antiherpetique
US20040023935A1 (en) * 2002-08-02 2004-02-05 Dey, L.P. Inhalation compositions, methods of use thereof, and process for preparation of same
US20040109826A1 (en) * 2002-12-06 2004-06-10 Dey, L.P. Stabilized albuterol compositions and method of preparation thereof
US20050208083A1 (en) 2003-06-04 2005-09-22 Nanobio Corporation Compositions for inactivating pathogenic microorganisms, methods of making the compositons, and methods of use thereof
EP1663999A2 (en) * 2003-08-29 2006-06-07 Ranbaxy Laboratories, Ltd. Inhibitors of phosphodiesterase type-iv
EP1694655A2 (en) * 2003-11-26 2006-08-30 Ranbaxy Laboratories Limited Phosphodiesterase inhibitors
US7618950B2 (en) * 2004-07-07 2009-11-17 Arigen Pharmaceuticals, Inc. Method for treatment and prevention of herpes zoster by topical application
EP2394651A1 (en) * 2005-03-30 2011-12-14 Novartis AG Penciclovir or Famciclovir for the Treatment of Recurrent Genital Herpes With a One-Day Application
US20070054834A1 (en) * 2005-04-11 2007-03-08 Nanobio Corporation Quaternary ammonium halides for treatment of infectious conditions
CA2618974C (en) * 2005-08-09 2014-01-28 Nanobio Corporation Nanoemulsion compositions having anti-inflammatory activity
EP1934219A1 (en) 2005-09-16 2008-06-25 Ranbaxy Laboratories Limited Substituted pyrazolo [3,4-b] pyridines as phosphodiesterase inhibitors
US7797337B2 (en) * 2005-09-29 2010-09-14 Scenera Technologies, Llc Methods, systems, and computer program products for automatically associating data with a resource as metadata based on a characteristic of the resource
EP1948167A1 (en) * 2005-10-19 2008-07-30 Ranbaxy Laboratories, Ltd. Compositions of phosphodiesterase type iv inhibitors
US20090221664A1 (en) 2005-10-19 2009-09-03 Abhijit Ray Pharmaceutical compositions of muscarinic receptor antagonists
FR2900577B1 (fr) * 2006-05-04 2008-09-12 Goemar Lab Sa Nouveaux medicaments pour les traitements contre le virus de l'herpes
US20110021473A1 (en) * 2006-09-22 2011-01-27 Ranbaxy Laboratories Limited Inhibitors of phosphodiesterase type-iv
WO2008035316A2 (en) * 2006-09-22 2008-03-27 Ranbaxy Laboratories Limited Phosphodiesterase inhibitors
EP1958947A1 (en) 2007-02-15 2008-08-20 Ranbaxy Laboratories Limited Inhibitors of phosphodiesterase type 4
EP2124943A1 (en) * 2007-03-14 2009-12-02 Ranbaxy Laboratories Limited Pyrazolo [3, 4-b]pyridine derivatives as phosphodiesterase inhibitors
EP2124944B1 (en) 2007-03-14 2012-02-15 Ranbaxy Laboratories Limited Pyrazolo[3,4-b]pyridine derivatives as phosphodiesterase inhibitors
EP2155209A4 (en) * 2007-04-26 2012-06-13 Univ Pennsylvania DNA polymerase inhibitor composition and method
EP2152304B1 (en) 2007-05-02 2018-08-22 The Regents of the University of Michigan Nanoemulsion therapeutic compositions and methods of using the same
JP4972062B2 (ja) * 2008-03-17 2012-07-11 メディヴィル・アクチエボラーグ 抗ウイルス製剤
EP2111861A1 (en) 2008-04-21 2009-10-28 Ranbaxy Laboratories Limited Compositions of phosphodiesterase type IV inhibitors
US20090291895A1 (en) * 2008-05-23 2009-11-26 Wong Scott W Methods and Compositions for the Treatment of Inflammatory Diseases
US20110065655A1 (en) * 2009-09-17 2011-03-17 Karry Whitten Therapeutic composition to treat lesions caused by herpes simplex virus
CN102049050B (zh) * 2009-11-02 2014-06-18 重庆华邦制药有限公司 抗疱疹病毒感染的药物组合物
EP2489354A1 (en) * 2011-02-18 2012-08-22 Vironova AB Pharmaceutical formulation of B220 for topical treatment of herpes
ITMI20111747A1 (it) * 2011-09-28 2013-03-29 Fidia Farmaceutici Composizioni farmaceutiche topiche comprendenti aciclovir
FR2983731B1 (fr) * 2011-12-07 2014-04-25 Univ Paris Descartes Emulsions topiques a base de melanges eutectiques d'anesthesiques locaux et d'acide gras
WO2014159731A1 (en) * 2013-03-13 2014-10-02 Nal Pharmaceuticals, Ltd A topical antiviral composition containing a local anesthetic and method of making the same
CN104324039A (zh) * 2014-10-20 2015-02-04 付茜 一种治疗人身体表面脂肪瘤的药剂及使用方法
CN108853140A (zh) * 2018-07-18 2018-11-23 豆立忠 一种多药物模块软膏及其制备方法
WO2020036545A1 (en) * 2018-08-17 2020-02-20 İlko İlaç Sanayi̇ Ve Ti̇caret A.Ş. Phase stable topical composition comprising acyclovir and hydrocortisone
CA3142831A1 (en) 2019-06-14 2020-12-17 Propella Therapeutics, Inc. Topical acyclovir formulations and uses thereof
CN112569243A (zh) * 2019-09-30 2021-03-30 神农医药科技有限公司 制备治疗阿尔茨海默病的药物
CN112704154A (zh) * 2020-12-24 2021-04-27 中国人民解放军66399部队 一种用于治疗宠物猫疱疹病毒的营养膏
US11951082B2 (en) * 2022-08-22 2024-04-09 Ford Therapeutics, Llc Composition of chlorhexidine

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3317384A (en) * 1964-06-08 1967-05-02 Upjohn Co Treatment of topical viral infections with glucocorticoids and nucleosides
US4512978A (en) * 1980-01-24 1985-04-23 Inwood Louis R Dermatological composition useful in the treatment of psoriasis
US4902678A (en) * 1982-02-12 1990-02-20 Syntex (U.S.A.) Inc. Anti-viral compositions
US4610868A (en) 1984-03-20 1986-09-09 The Liposome Company, Inc. Lipid matrix carriers for use in drug delivery systems
US5223263A (en) 1988-07-07 1993-06-29 Vical, Inc. Liponucleotide-containing liposomes
EP0594223B1 (en) * 1985-09-17 2000-03-01 The Wellcome Foundation Limited Combination of therapeutic nucleosides and further therapeutic agents.
US4942031A (en) 1988-02-23 1990-07-17 Levin Robert H Compositions containing LYCD and other topically active medicinal ingredients
US5023090A (en) 1989-08-16 1991-06-11 Levin Robert H Topical compositions containing LYCD and other topically active medicinal ingredients for the treatment of ACNE
WO1990006775A1 (en) * 1988-12-14 1990-06-28 Liposome Technology, Inc. A novel nonphospholipid liposome composition for sustained release of drugs
AU636255B2 (en) * 1990-11-05 1993-04-22 Arthropharm Pty Ltd Use of a topical formulation for the treatment of viral infections and neoplastic disorders
US5856364A (en) * 1991-03-01 1999-01-05 Warner Lambert Company Therapeutic antiviral-wound healing compositions and methods for preparing and using same
ES2181673T3 (es) 1991-05-01 2003-03-01 Jackson H M Found Military Med Procedimiento de tratamiento de las enfermedades respiratorias infecciosas.
IL104283A (en) * 1992-12-30 1996-12-05 Agis Ind 1983 Ltd Non-emulsion antiviral topical pharmaceutical composition comprising acyclovir an aqueous gel agent and an alkali oleate
GB9315755D0 (en) * 1993-07-30 1993-09-15 Wellcome Found Stabilized formulation
DZ1965A1 (fr) * 1995-02-06 2002-07-17 Astra Ab Composition pharmaceutique nouvelle.
GB9601544D0 (en) 1996-01-26 1996-03-27 Smithkline Beecham Plc Pharmaceuticals

Also Published As

Publication number Publication date
IL116913A0 (en) 1996-05-14
HRP960034A2 (en) 1997-10-31
HK1004368A1 (en) 1998-11-27
CA2211389C (en) 2007-11-20
DZ1966A1 (fr) 2002-10-15
FR10C0038I2 (no) 2011-04-29
CA2211389A1 (en) 1996-08-15
EP1419803B1 (en) 2009-01-21
ZA96527B (en) 1996-08-06
FI973243A (fi) 1997-08-06
YU7296A (sh) 1998-08-14
EP1419803A3 (en) 2004-06-09
JPH11506417A (ja) 1999-06-08
DE69637828D1 (de) 2009-03-12
NO314220B1 (no) 2003-02-17
DE69632034T2 (de) 2004-10-14
DK0809498T3 (da) 2004-05-10
KR100431042B1 (ko) 2004-06-16
MA23800A1 (fr) 1996-10-01
PT809498E (pt) 2004-06-30
CN1131034C (zh) 2003-12-17
FR10C0038I1 (no) 2010-10-15
US6337324B1 (en) 2002-01-08
TNSN96024A1 (fr) 2005-03-15
HRP960034B1 (en) 2002-02-28
JP2007284452A (ja) 2007-11-01
DE69632034D1 (de) 2004-05-06
MY119365A (en) 2005-05-31
AU4682196A (en) 1996-08-27
WO1996024355A1 (en) 1996-08-15
ES2214528T3 (es) 2004-09-16
FI119415B (fi) 2008-11-14
DE122010000032I1 (de) 2010-10-21
CN1179718A (zh) 1998-04-22
EP0809498B1 (en) 2004-03-31
SI0809498T1 (en) 2004-12-31
USRE39264E1 (en) 2006-09-05
TW438585B (en) 2001-06-07
JP4260220B2 (ja) 2009-04-30
SA96160590B1 (ar) 2005-10-05
YU49477B (sh) 2006-05-25
KR19980701959A (ko) 1998-06-25
NZ301407A (en) 1999-01-28
FI973243A0 (fi) 1997-08-06
AR002030A1 (es) 1998-01-07
EP1419803A2 (en) 2004-05-19
NO973612D0 (no) 1997-08-05
ATE262907T1 (de) 2004-04-15
ATE421358T1 (de) 2009-02-15
EP0809498A1 (en) 1997-12-03
AU716809B2 (en) 2000-03-09

Similar Documents

Publication Publication Date Title
NO973612D0 (no) Nytt farmasöytisk preparat
NO943888D0 (no) Farmasöytisk preparat
NO20001160L (no) Nytt skumdannende farmasøytisk preparat
NO20021172L (no) Farmasöytisk sammensetning
BR9610153A (pt) Formulações farmacêuticas
BR9611626A (pt) Formulações farmacéuticas
NO963032L (no) Oralt preparat
BR9610396A (pt) Formulação farmacêutica
NO20005399D0 (no) Farmasøytisk preparat
BR9610214A (pt) Compostos farmacéuticos
NO973610D0 (no) Nytt farmasöytisk preparat
LV11727A (lv) Farmaceitiska kompozicija
NO995039D0 (no) Gastrisk bibeholdt farmasöytisk preparat
NO973611D0 (no) Nytt farmasöytisk preparat
FI973280A (fi) Farmaseuttinen koostumus
NO950950D0 (no) Farmasöytisk preparat
NO965448D0 (no) Farmasöytiske forbindelser
BR9605777A (pt) Composição farmacêutica
BR9605131A (pt) Composição farmacêutica
NO931014D0 (no) Farmasoeytisk preparat
DE29618094U1 (de) Pharmazeutisches Präparat
NO921691D0 (no) Farmasoeytisk preparat
SE9502290D0 (sv) New Preparation
FI3862U1 (fi) Geelimuotoinen farmaseuttinen valmiste
SE9502453D0 (sv) Drug formulations

Legal Events

Date Code Title Description
MK1K Patent expired